The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment
Abstract
OBJECTIVE: Type 2 diabetes is a slowly progressive disease, in which the gradual deterioration of glucose tolerance is associated with the progressive decrease in β-cell function. Hyperglycemia per se has deleterious effects on both beta-cell function and insulin action, which are partially reversible by the short-term control of blood glucose levels. We hypothesized that the induction of euglycemia, using intensive insulin therapy at the time of clinical diagnosis, could lead to a significant improvement in insulin secretion and action and thus alter the clinical course of the disease. RESEARCH DESIGN AND METHODS: Thirteen newly diagnosed diet-unresponsive type 2 diabetic patients were treated with continuous subcutaneous insulin infusion (CSII) for 2 weeks and followed longitudinally while being treated with diet alone. RESULTS: Four patients were considered therapeutic failures since CSII failed to induce euglycemia (n = 1) or glucose control deteriorated within 6 months after CSII (n = 3). The remaining nine patients were maintained on diet alone with adequate control from 9 to > 50 months (median ± SE, 26 ± 4.8 months). In five patients, glycemic control deteriorated after 9–36 months, but a repeat 2-week CSII treatment reestablished control in four patients. One of these patients underwent a third CSII treatment 13 months later. At the time this article was written, six patients of the initial group were still controlled without medication 16–59 months (median ± SE, 45.5 ± 6.6 months) after the initiation of treatment. Body weight remained unchanged in all patients. CONCLUSIONS: These findings suggest that in a significant proportion of type 2 diabetic patients who fail to respond to dietary measures, short-term intensive insulin treatment can effectively establish responsiveness, allowing long-term glycemic control without medication. Further studies are required to establish whether simpler treatment regimens could be equally effective. If the hypothesis offered here finds support, present approaches to the management of newly diagnosed type 2 diabetes may need to be revised.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mounting evidence suggests that aggressive lowering of glycemia, especially with insulin therapy, in newly diagnosed diabetes can result in sustained remissions, i.e., normoglycemia without need for glucose-lowering medications (87,88).”
From Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) · cites this paper as [87]
Citations
Cites
Nonketotic diabetes mellitus: Insulin deficiency or insulin resistance?
Reaven, G. M., Bernstein, R., Davis, B. M., & Olefsky, J. M. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90536-2 · Cited by 356
Leahy, J. L., Cooper, H. E., Deal, D. A., & Weir, G. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112389 · Cited by 289
Glibenclamide-associated hypoglycaemia: A report on 57 cases
Asplund, K., Wiholm, B. ‐., & Lithner, F. (1983) · Diabetologia · doi:10.1007/bf00257338 · Cited by 255
Basal and 24-h C-peptide and insulin secretion rate in normal man
Kruszynska, Y. T., Home, P., Hanning, I., & Alberti, K. G. M. M. (1987) · Diabetologia · doi:10.1007/bf01788901 · Cited by 119
Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?
Leibowitz, G., & Cerasi, E. (1996) · Diabetologia · doi:10.1007/bf00403296 · Cited by 106
Self-citationVuorinen-Markkola, H., Koivisto, V. A., & Yki‐Järvinen, H. (1992) · Diabetes · doi:10.2337/diab.41.5.571 · Cited by 104
Gläser, B., Leibovitch, G., Nesher, R., HARTLING, S. G., Binder, C., & Cerasi, E. (1988) · European Journal of Endocrinology · doi:10.1530/acta.0.1180365 · Cited by 94
Self-citationInsulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?
Cerasi, E. (1995) · Diabetologia · doi:10.1007/bf00400591 · Cited by 77
Self-citationLong-Term Normoglycemic Remission in Black Newly Diagnosed NIDDM Subjects
Banerji, M. A., Chaiken, R. L., & Lebovitz, H. E. (1996) · Diabetes · doi:10.2337/diab.45.3.337 · Cited by 67
Yki-Järvinen, H., Esko, N., Helve, E., & Taskinen, M. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90412-3 · Cited by 50
Cited by
Sorted by citations
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Pharmacologic Therapy for Type 2 Diabetes Mellitus
DeFronzo, R. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00008 · Cited by 1,173
Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60762-x · Cited by 780
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
WAJCHENBERG, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 722
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetologia · doi:10.1007/s00125-008-1157-y · Cited by 712
Pancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
Wang, Z., York, N., Nichols, C. G., & Remedi, M. S. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.010 · Cited by 411
Initial management of glycemia in type 2 diabetes mellitus
Nathan, D. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp021106 · Cited by 359
Standards of care for type 2 diabetes in China
Weng, J., Ji, L., Jia, W., Lu, J., Zhou, Z., Zou, D., Zhu, D., Chen, L., Chen, L., Guo, L., et al. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2827 · Cited by 315
Li, Y., Xu, W., Liao, Z., Yao, B., Chen, X., Huang, Z., Hu, G., & Weng, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2597 · Cited by 324
Raskin, P., Bode, B. W., Marks, J. B., Hirsch, I. B., Weinstein, R. L., McGill, J. B., Peterson, G. E., Mudaliar, S. R., & Reinhardt, R. R. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2598 · Cited by 248
Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes
Ryan, E. A., Imes, S., & Wallace, C. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1028 · Cited by 241
Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal Transplantation
Hecking, M., Haidinger, M., Döller, D., Werzowa, J. M., Tura, A., Zhang, J., Tekoglu, H., Pleiner, J., Wrba, T., Rasoul‐Rockenschaub, S., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011080835 · Cited by 226
Glucotoxicity and β-Cell Failure in Type 2 Diabetes Mellitus
Kaiser, Ν., Leibowitz, G., & Nesher, R. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.1.5 · Cited by 213
Continuous Subcutaneous Insulin Infusion
Lenhard, M. J., & Reeves, G. D. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.19.2293 · Cited by 204
Metabolic Stress and Compromised Identity of Pancreatic Beta Cells
Swisa, A., Gläser, B., & Dor, Y. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00021 · Cited by 170
Measuring Psychological Insulin Resistance
Larkin, M., Capasso, V. A., Chen, C., Mahoney, E. K., Hazard, B. P., Cagliero, E., & Nathan, D. M. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708317869 · Cited by 158
Ferrannini, E., Camastra, S., Gastaldelli, A., Sironi, A. M., Natali, A., Muscelli, E., Mingrone, G., & Mari, A. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s26 · Cited by 156
Oral insulin – a review of current status
Iyer, H. V., Khedkar, A., & Verma, M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01150.x · Cited by 144
Haak, T., Meinicke, T. W., Jones, R., Weber, S., von Eynatten, M., & Woerle, H. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01590.x · Cited by 139
Pancreatic β-cell identity in diabetes
Remedi, M. S., & Emfinger, C. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12727 · Cited by 128
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Hecking, M., Werzowa, J., Haidinger, M., Horl, W. H., Pascual, J., Budde, K., Luan, F. L., Ojo, A., de Vries, A. P. J., Porrini, E., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs583 · Cited by 120
McFarlane, S. I., Chaiken, R. L., Hirsch, S. R., Harrington, P., Lebovitz, H. E., & Banerji, M. A. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00395.x · Cited by 110
Targeting β-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus
Leahy, J. L., Hirsch, I. B., PETERSON, K. A., & Schneider, D. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0668 · Cited by 110
Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.
Mayfield, J. A., & White, R. D. (2004) · PubMed · Cited by 108
The Physiological Rationale for Oral Insulin Administration
Arbit, E. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/1520915041705929 · Cited by 109
Giaccari, A., Sorice, G. P., & Muscogiuri, G. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.03.018 · Cited by 109
Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes
Owens, D. R. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0081 · Cited by 108
We Can Change the Natural History of Type 2 Diabetes
Phillips, L. S., Ratner, R. E., Buse, J. B., & Kahn, S. E. (2014) · Diabetes Care · doi:10.2337/dc14-0817 · Cited by 109
Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data
Brown, R. J., & Rother, K. I. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00272.x · Cited by 102
β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy
Harrison, L., ADAMS-HUET, B. A., Raskin, P., & Lingvay, I. (2012) · Diabetes Care · doi:10.2337/dc11-2170 · Cited by 100
Bruttomesso, D., Costa, S., & Baritussio, A. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.931 · Cited by 98
Kibirige, D., Lumu, W., Jones, A. G., Smeeth, L. L., Hattersley, A. T., & Nyirenda, M. (2019) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-019-0077-8 · Cited by 98
Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes
Lingvay, I., Legendre, J. L., Kaloyanova, P. F., Zhang, S., ADAMS-HUET, B. A., & Raskin, P. (2009) · Diabetes Care · doi:10.2337/dc09-0653 · Cited by 95
Johnston, R., Uthman, O. A., Cummins, E., Clar, C., Royle, P., Colquitt, J. L., Tan, B. K., Clegg, A. J., Shantikumar, S., Court, R. A., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21020 · Cited by 84
β-Cell failure in type 2 diabetes
Leibowitz, G., Kaiser, N., & Cerasi, E. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00094.x · Cited by 78
Self-citationß‐cell function and anti‐diabetic pharmacotherapy
Prato, S. D., Bianchi, C., & Marchetti, P. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.770 · Cited by 79
Emerging treatment options for type 2 diabetes
Piya, M. K., Tahrani, A. A., & Barnett, A. H. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03711.x · Cited by 73
Dietary strategies for remission of type 2 diabetes: A narrative review
Brown, A. C., McArdle, P., Taplin, J., Unwin, D., Unwin, J., Deakin, T., Wheatley, S. D., Murdoch, C., Malhotra, A., & Mellor, D. D. (2021) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12938 · Cited by 74
Preventing and Treating Obesity in Girls and Young Women to Curb the Epidemic
Kral, J. G. (2004) · Obesity Research · doi:10.1038/oby.2004.193 · Cited by 65
Hanefeld, M., Fleischmann, H., Siegmund, T., & Seufert, J. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00855-5 · Cited by 68
Park, S., & Choi, S. B. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.343 · Cited by 62
Intensive insulin therapy in newly diagnosed type 2 diabetes
Retnakaran, R. R., & Drucker, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60736-9 · Cited by 61
Pancreatic β-Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes
Dahan, T., Ziv, O., Horwitz, E. P., Zemmour, H., Lavi, J., Swisa, A., Leibowitz, G., Ashcroft, F. M., Veld, P. I. '., Gläser, B., et al. (2016) · Diabetes · doi:10.2337/db16-0641 · Cited by 62
Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes
Page, K. A., & Reisman, T. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0363-2 · Cited by 62
An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
Mahgoub, M., Ali, I. I., Adeghate, J. O., Tekes, K., Kalász, H., & Adeghate, E. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119328 · Cited by 65
Chen, A., Huang, Z., Wan, X., Deng, W., Wu, J.-Y., Li, L., Cai, Q., Xiao, H., & Li, Y. (2012) · Diabetes Care · doi:10.2337/dc11-1638 · Cited by 61
Vinik, A. I. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.005 · Cited by 57
Short‐term intensified insulin treatment in type 2 diabetes: long‐term effects on β‐cell function
Retnakaran, R. R., & Zinman, B. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01658.x · Cited by 56
The response to short‐term intensive insulin therapy in type 2 diabetes
Retnakaran, R. R., Yakubovich, N., Qi, Y., Opsteen, C., & Zinman, B. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01129.x · Cited by 57
Benefits of timely basal insulin control in patients with type 2 diabetes
Lovre, D., & Fonseca, V. A. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.018 · Cited by 55
Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial
McInnes, N., Smith, A., Otto, R., Vandermey, J., Punthakee, Z., Sherifali, D., Balasubramanian, K., Hall, S., & Gerstein, H. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3373 · Cited by 52
Early Insulin Treatment in Type 2 Diabetes
Meneghini, L. (2009) · Diabetes Care · doi:10.2337/dc09-s320 · Cited by 53
Early therapy for type 2 diabetes in China
Yang, W., & Weng, J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70136-6 · Cited by 53
Systematic review of feline diabetic remission: Separating fact from opinion
Gostelow, R., Forcada, Y., Graves, T. K., Church, D. B., & Niessen, S. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.08.014 · Cited by 57
Beta cells in type 2 diabetes – a crucial contribution to pathogenesis
Maedler, K. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00718.x · Cited by 53
Ringborg, A., Lindgren, P., Yin, D., Martinell, M., & Stålhammar, J. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.11.006 · Cited by 53
Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice
Heinemann, L., & Parkin, C. G. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4568903 · Cited by 48
Pistrosch, F., Köhler, C. U., Schäper, F., Landgraf, W., Forst, T. M., & Hanefeld, M. (2013) · Acta Diabetologica · doi:10.1007/s00592-012-0451-9 · Cited by 48
Early intensive insulin treatment for induction of long‐term glycaemic control in type 2 diabetes
Gläser, B., & Cerasi, E. (1999) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.00015.x · Cited by 44
Self-citationHirao, K., Arai, K., Yamauchi, M., Takagi, H., & Kobayashi, M. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.08.011 · Cited by 44
Diabetes in African Americans: Unique pathophysiologic features
Banerji, M. A. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0027-3 · Cited by 41
Insulin Therapy in Type 2 Diabetes Mellitus
Leahy, J. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.004 · Cited by 41
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Spectrum · doi:10.2337/diaspect.22.1.6 · Cited by 40
Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections
Li, F.-F., Fu, L., Zhang, W., Su, X., Wu, J.-D., Sun, J., Ye, L., & Ma, J. (2015) · Journal of Diabetes Research · doi:10.1155/2016/1028945 · Cited by 39
Dysfunctional insulin secretion in type 2 diabetes: role of metabolic abnormalities
Grill, V., & Björklund, A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000705 · Cited by 38
β‐Cell mass plasticity in type 2 diabetes
Prato, S. D., Wishner, W. J., Gromada, J., & Schluchter, B. J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00360.x · Cited by 39
Treatment of Type 2 Diabetes With Combined Therapy
Massi‐Benedetti, M., & Orsini-Federici, M. (2008) · Diabetes Care · doi:10.2337/dc08-s233 · Cited by 37
Clinical Approaches to Preserve β-Cell Function in Diabetes
WAJCHENBERG, B. L. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_23 · Cited by 38
Park, S., & Choi, S. B. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.728 · Cited by 38
The role of the beta cell in type 2 diabetes: new findings from the last 5 years
Yau, B., Ghislain, J. J., Kebede, M. A., Hughes, J. W., & Poitout, V. (2025) · Diabetologia · doi:10.1007/s00125-025-06499-z · Cited by 42
The role of insulin pump therapy for type 2 diabetes mellitus
Landau, Z., Raz, I., Wainstein, J., Bar‐Dayan, Y., & Cahn, A. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2822 · Cited by 36
Hanefeld, M. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.08.006 · Cited by 43
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production
Rohli, K. E., Boyer, C. K., Blom, S. E., & Stephens, S. B. (2022) · Biomolecules · doi:10.3390/biom12020335 · Cited by 36
The case for insulin treatment early in type 2 diabetes.
Palumbo, P. J. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.5.385 · Cited by 34
Huang, Z., Wan, X., Liu, J., Deng, W., Chen, A., Liu, L., Liu, J., Wei, G., Li, H., Fang, D., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0013 · Cited by 33
Mazzaglia, G., Yurgin, N., Boye, K. S., Trifirò, G., Cottrell, S., Allen, E., Filippi, A., Medea, G., & Cricelli, C. A. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.009 · Cited by 34
Complementing Insulin Therapy to Achieve Glycemic Control
Barnett, A. H. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0039-y · Cited by 33
Early Insulinization to Prevent Diabetes Progression
Raz, I., & Mosenzon, O. (2013) · Diabetes Care · doi:10.2337/dcs13-2014 · Cited by 30
Chon, S., Oh, S., Kim, S. W., Kim, J., Kim, Y. S., & Woo, J. (2010) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2010.25.3.273 · Cited by 30
Rabin, D. L., Jetty, A., Petterson, S. M., Saqr, Z., & Froehlich, A. (2016) · Diabetes Care · doi:10.2337/dc16-1579 · Cited by 30
Chen, H., An, R., Hu, S., Wei-lin, M., Xin, X., & Jia, W. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.001 · Cited by 30
Retnakaran, R. R., Qi, Y., Opsteen, C., Vivero, E. J. A. R., & Zinman, B. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01254.x · Cited by 30
McInnes, N., Hall, S., Lochnan, H. A., Harris, S. B., Punthakee, Z., Sigal, R. J., HRAMIAK, I. M., Azharuddin, M. K., Liutkus, J., Yale, J., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15234 · Cited by 30
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Clinical Diabetes · doi:10.2337/diaclin.27.1.4 · Cited by 29
Liu, Y., Chen, Y., Ma, J., Lin, J., Liu, C., Li, X., Xu, Y., Kuang, H., Shi, L., Xue, Y., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081820 · Cited by 30
In support of an early polypharmacy approach to the treatment of type 2 diabetes
Wright, E. E., Stonehouse, A. H., & Cuddihy, R. M. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01255.x · Cited by 27
Mu, P., Chen, Y., Lu, H., Wen, X., Zhang, Y., Xie, R., Shu, J., Wang, M., & Zeng, L. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1292 · Cited by 27
Liu, L., Wan, X., Liu, J., Huang, Z., Cao, X., & Li, Y. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0055 · Cited by 27
Kärvestedt, L., ANDERSSON, G., Efendić, S., & Grill, V. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00956.x · Cited by 27
Insulin Therapy in Type 2 Diabetes
Campbell, R. K., & White, J. R. (2002) · Journal of the American Pharmaceutical Association (1996) · doi:10.1331/108658002763029580 · Cited by 27
Insulin: A new era for an old hormone☆
Sabetsky, V., & Ekblom, J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.07.010 · Cited by 25
Wang, H., Kuang, J., Xu, M., Gao, Z., Li, Q., Liu, S., Zhang, F., Yu, Y., Liang, Z., Zhao, W., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01468 · Cited by 27
Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus
Kim, J., & Kwon, H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0377 · Cited by 31
Bi, Y., Sun, W., Chen, X., Li, M., Liang, H., Cai, M., Zhu, Y., He, X., Xu, F. L., & Weng, J. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0038-7 · Cited by 26
Effect of short‐term intensive insulin therapy on quality of life in type 2 diabetes
Opsteen, C., Qi, Y., Zinman, B., & Retnakaran, R. R. (2010) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01552.x · Cited by 26
Failure of beta-cell adaptation in type 2 diabetes: Lessons from animal models
Kaiser, N. (2009) · Frontiers in bioscience · doi:10.2741/3296 · Cited by 26
Therapeutic approaches based on beta-cell mass preservation and/or regeneration
Robert, A. R. (2009) · Frontiers in bioscience · doi:10.2741/3345 · Cited by 25
Preservation of Beta-Cell Function in Type 2 Diabetes
Nyalakonda, K., Sharma, T., & Ismail‐Beigi, F. (2010) · Endocrine Practice · doi:10.4158/ep10112.ra · Cited by 25
Short‐term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps
Weng, J., Retnakaran, R. R., Ammini Ariachery, C., Ji, L., Meneghini, L., Yang, W., & Woo, J. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2603 · Cited by 25
Reznik, Y. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.08.002 · Cited by 23
Metadata
- Authors
- Ilkova, H., Glaser, B., Tunçkale, A., Bagriaçik, N., & Cerasi, E.
- Affiliations
- Istanbul University-Cerrahpaşa (TR)
- Department of Endocrinology and Metabolism, Hebrew University Hadassah Medical Center Jerusalem, Israel
- Department of Internal Medicine, Division of Metabolism and Diabetes, Istanbul University Cerrahpasa Medical Faculty Istanbul, Turkey
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1997-09-01
- Volume
- 20
- Issue
- 9
- Pages
- 1353-1356
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2094434238
- Cited by
- 269
- References
- 13
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 12 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 7 · 2018: 10 · 2017: 7 · 2016: 14 · 2015: 13 · 2014: 17 · 2013: 18 · 2012: 19
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, newly diagnosed diabetes, intensive insulin therapy, insulin pump therapy, glycemic control, beta-cell function, insulin secretion, insulin action
- MeSH terms
- Adult, Aged, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Infusion Pumps, Insulin, Male, Middle Aged, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review